Evidence Level:Resistant: C3 – Early Trials
New
Title:
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Excerpt:Patients with basal-like GATA6low tumours have a shorter survival and have a distinctly poor response to adjuvant 5-fluorouracil (5-FU)/leucovorin.
DOI:10.1136/gutjnl-2015-311256